ATOSSA THERAPEUTICS, INC. Operating Lease, Payments
ATOSSA THERAPEUTICS, INC. (ATOS) reported Operating Lease, Payments of $19.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2022-02-28
- ATOSSA THERAPEUTICS, INC. operating lease, payments for the quarter ending 2021-12-31 was $900.00, a 92.91% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. operating lease, payments for the quarter ending 2021-09-30 was $3.70K, a 71.32% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. operating lease, payments for the quarter ending 2021-06-30 was $3.70K, a 74.83% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. operating lease, payments for the quarter ending 2021-03-31 was $10.70K, a 27.21% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. operating lease, payments for fiscal 2021 was $19.00K, a 65.45% decline from fiscal 2020.
- ATOSSA THERAPEUTICS, INC. operating lease, payments for fiscal 2020 was $55.00K, a 6.46% decline from fiscal 2019.
- ATOSSA THERAPEUTICS, INC. operating lease, payments for fiscal 2019 was $58.80K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 6 month as first filed | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|---|
| 2021-12-31 | $900.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $4.60K derived: sum of 2 quarters · filed 2022-02-28 | $8.30K derived: sum of 3 quarters · filed 2022-02-28 | $19.00K 10-K · filed 2022-02-28 | ||
| 2021-09-30 | $3.70K 10-Q · filed 2021-11-15 | $7.40K derived: sum of 2 quarters · filed 2021-11-15 | $18.10K 10-Q · filed 2021-11-15 | $30.80K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2021-06-30 | $3.70K 10-Q · filed 2021-08-13 | $14.39K 10-Q · filed 2021-08-13 | $27.10K derived: sum of 3 quarters · filed 2022-02-28 | $40.00K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2021-03-31 | $10.70K 10-Q · filed 2021-05-14 | $23.40K derived: sum of 2 quarters · filed 2022-02-28 | $36.30K derived: sum of 3 quarters · filed 2022-02-28 | $51.00K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-12-31 | $12.70K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $25.60K derived: sum of 2 quarters · filed 2022-02-28 | $40.30K derived: sum of 3 quarters · filed 2022-02-28 | $55.00K 10-K · filed 2022-02-28 | $54.90K 10-K · filed 2021-03-31 | |
| 2020-09-30 | $12.90K 10-Q · filed 2021-11-15 | $27.60K derived: sum of 2 quarters · filed 2021-11-15 | $42.30K 10-Q · filed 2021-11-15 | $58.40K derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $14.70K 10-Q · filed 2021-08-13 | $28.20K 10-Q · filed 2021-08-13 | $29.40K 10-Q · filed 2020-08-13 | $45.50K derived: sum of 3 quarters · filed 2021-08-13 | $59.40K derived: sum of 4 quarters · filed 2021-08-13 | |
| 2020-03-31 | $14.70K 10-Q · filed 2021-05-14 | $30.80K derived: sum of 2 quarters · filed 2021-05-14 | $44.70K derived: sum of 3 quarters · filed 2021-05-14 | $58.90K derived: sum of 4 quarters · filed 2021-05-14 | ||
| 2019-12-31 | $16.10K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $30.00K derived: sum of 2 quarters · filed 2021-03-31 | $44.20K derived: sum of 3 quarters · filed 2021-03-31 | $58.80K 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $13.90K 10-Q · filed 2020-11-13 | $28.10K derived: sum of 2 quarters · filed 2020-11-13 | $42.70K 10-Q · filed 2020-11-13 | |||
| 2019-06-30 | $14.20K 10-Q · filed 2020-08-13 | $28.20K 10-Q · filed 2020-08-13 | $28.80K 10-Q · filed 2019-08-13 | |||
| 2019-03-31 | $14.60K 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |